Aurora Research Institute: Research and clinical trials at Aurora Health Care, part of Advocate Aurora Health, are advancing patient care in some of eastern Wisconsin’s most pressing areas of need, including cardiovascular disease, cancer, and neurological disorders. Aurora Research Institute’s history of research innovation has contributed to many of today’s safe, effective treatments. Its current efforts are yielding scientific discoveries that give people hope for a healthier future. Focusing on people, its research is dedicated to improving population-wide medical care, starting right in its own communities. Aurora is an integrated health system, which helps its scientists and clinicians quickly spread new medical knowledge across more than 150 clinics in 90 communities.
Bio Highlights: Dr. Garlie has more than 25 years of progressive research experience, including 10 years as a leader in research administration in laboratory and outcomes research and clinical trials. Her leadership has spanned multiple clinical areas, including oncology, cardiology, and neuroscience. She oversees a research program that comprises more than 500 research projects, including 263 clinical trials with more than 2,000 consented research participants within Aurora’s footprint in Wisconsin in 2019.
Dr. Garlie currently serves as the research institute’s quality assurance council chair and the compliance liaison to research. She served for 10 years on Aurora’s institutional review board. She has directed a stem cell transplant program, and cell processing lab accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and served as a FACT inspector on behalf of Aurora. In addition, she has strengthened Aurora’s medical research program by coordinating the design, construction, and start-up of a large research laboratory, a rodent vivarium, and a neuro-anatomy laboratory.
Before becoming an administrative leader for Aurora Research Institute, Dr. Garlie conducted cell-based immunotherapy research to support investigational new drug applications to the Food and Drug Administration and participated as a co-investigator on clinical trials based on her work in the lab.
Dr. Garlie earned a doctorate in pathology and immunology from Medical College of Wisconsin in Milwaukee and a Bachelor of Science in bacteriology from the University of Wisconsin-Madison.